Accelerated Pharma, Inc.
Records under this name other than patents Accelerated Pharma, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 4 of 4 · Back to Accelerated Pharma, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,178,564 | Use of Picoplatin to Treat Colorectal Cancer Lapsed on the fee record Ended May 15, 2020 · Low confidence | Lapsed on the fee record | Ended May 15, 2020 | Low confidence |
| US 8,173,686 | Use of Picoplatin to Treat Colorectal Cancer Lapsed on the fee record Ended May 8, 2020 · Low confidence | Lapsed on the fee record | Ended May 8, 2020 | Low confidence |
| US 8,168,661 | Use of Picoplatin to Treat Colorectal Cancer Lapsed on the fee record Ended May 1, 2020 · Low confidence | Lapsed on the fee record | Ended May 1, 2020 | Low confidence |
| US 8,168,662 | Use of Picoplatin to Treat Colorectal Cancer Lapsed on the fee record Ended May 1, 2020 · Low confidence | Lapsed on the fee record | Ended May 1, 2020 | Low confidence |